AIDS Treatment Data Network
611 Broadway, Suite 613, New York, NY, 10012 • www.atdn.org • Tel: (212) 260-8868 • (NYS) 800-734-7104
The Access Project collects and distributes information about medications available for HIV/AIDS and hepatitis co-infection through Medicaid, Medicare Part D, AIDS Drug Assistance Programs (ADAPs), and pharmaceutical industry sponsored patient assistance and expanded access programs (EAP). The Access Project is a program of the The Network (network@atdn.org)

Boehringer Ingelheim
Cares Foundation

Products covered:

Aggrenox (dipyridamole/aspirin)
Aptivus (tipranavir)
Atrovent (ipratropium bromide)
Combivent (ipratropium bromide and albuterol sulfate)
Flomax (tamsulosin)
Mirapex (pramipexole dihydrochloride) tablets
Mobic (meloxicam)
Catapres-TTS (clonidine)
Micardis (telmisartan)
Spiriva HandiHaler (tiotropium bromide inhalation powder)
Viramune (nevirapine)


Contact: 1-800-556-8317
http://us.boehringer-ingelheim.com
To be eligible for the program, patients must meet the following criteria:

  • Patient must be a U.S. citizen or legal resident of the U.S.
  • Patient and physician must submit a completed, signed application
  • Patient must meet certain financial criteria (depending upon the family size, the income criteria is approximately 200% of the federal poverty level)
  • Patient must not have private, public or government insurer drug coverage.

To receive an application or inquire about the Patient Assistance Program please call 1-800-556-8317. To apply online go to www.RxHope.com. Please note, while people of all ages are eligible for the program, applications can be sent only to people at least 18 years of age.

About The Network - Donate - About The Access Project
Last modified: 11/16/2007
© 2007 The Network